Published in J Cell Biochem on May 11, 2016
Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation. PLoS One (2016) 0.75
Engineering S. equi subsp. zooepidemicus towards concurrent production of hyaluronic acid and chondroitin biopolymers of biomedical interest. AMB Express (2017) 0.75
Isolation and characterization of human articular chondrocytes from surgical waste after total knee arthroplasty (TKA). PeerJ (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
SOX9 directly regulates the type-II collagen gene. Nat Genet (1997) 4.88
Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell (1978) 2.39
Engineering cartilage tissue. Adv Drug Deliv Rev (2007) 2.08
Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol (2010) 1.33
Changes in the ratio of type-I and type-II collagen expression during monolayer culture of human chondrocytes. J Bone Joint Surg Br (2004) 1.22
Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol (1999) 1.18
SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell Biol (2003) 1.05
Immunomodulatory and anti-inflammatory effects of chondroitin sulphate. J Cell Mol Med (2009) 1.02
Chondroitin sulfate increases hyaluronan production by human synoviocytes through differential regulation of hyaluronan synthases: Role of p38 and Akt. Arthritis Rheum (2009) 0.99
Disaccharide composition of hyaluronan and chondroitin/dermatan sulfate. Analysis with fluorophore-assisted carbohydrate electrophoresis. Methods Mol Biol (2001) 0.99
Cartilage tissue engineering: molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction. Biochim Biophys Acta (2014) 0.98
Pharmacoproteomic study of the effects of chondroitin and glucosamine sulfate on human articular chondrocytes. Arthritis Res Ther (2010) 0.95
Nasal septum-derived multipotent progenitors: a potent source for stem cell-based regenerative medicine. Stem Cells Dev (2011) 0.94
Igf-I extends the chondrogenic potential of human articular chondrocytes in vitro: molecular association between Sox9 and Erk1/2. Biochem Pharmacol (2006) 0.93
Tissue-engineered human nasal septal cartilage using the alginate-recovered-chondrocyte method. Laryngoscope (2004) 0.92
Human cartilage engineering: chondrocyte extraction, proliferation, and characterization for construct development. Ann Plast Surg (1999) 0.90
Production of chondroitin sulfate and chondroitin. Appl Microbiol Biotechnol (2010) 0.89
Optimization of chondrocyte isolation and characterization for large-scale cartilage tissue engineering. J Surg Res (2012) 0.89
Expansion of human articular chondrocytes and formation of tissue-engineered cartilage: a step towards exploring a potential use of matrix-induced cell therapy. Tissue Cell (2010) 0.86
Nanotechnology biomimetic cartilage regenerative scaffolds. Arch Plast Surg (2014) 0.86
In vitro analysis of the effects on wound healing of high- and low-molecular weight chains of hyaluronan and their hybrid H-HA/L-HA complexes. BMC Cell Biol (2015) 0.85
Effect of genipin-crosslinked chitin-chitosan scaffolds with hydroxyapatite modifications on the cultivation of bovine knee chondrocytes. Biotechnol Bioeng (2006) 0.84
Growth and phenotype of low-density nasal septal chondrocyte monolayers. Otolaryngol Head Neck Surg (2005) 0.84
Effect of collagen type I or type II on chondrogenesis by cultured human articular chondrocytes. Tissue Eng Part A (2012) 0.83
Isolation of human nasoseptal chondrogenic cells: a promise for cartilage engineering. Stem Cell Res (2011) 0.82
Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence? Curr Med Res Opin (2013) 0.82
Intra-articular use of a medical device composed of hyaluronic acid and chondroitin sulfate (Structovial CS): effects on clinical, ultrasonographic and biological parameters. BMC Res Notes (2012) 0.82
Hyaluronic acid in combination with chondroitin sulfate and hyaluronic acid improved the degeneration of synovium and cartilage equally in rabbits with osteoarthritis. Drug Discov Ther (2011) 0.82
Comparison of articular and auricular cartilage as a cell source for the autologous chondrocyte implantation. J Orthop Res (2009) 0.81
Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Res Ther (2012) 0.81
Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms. Oncol Rep (2011) 0.80
Biological characterization of oxidized hyaluronic acid/resveratrol hydrogel for cartilage tissue engineering. J Biomed Mater Res A (2013) 0.79
Pharmacological therapies for osteoarthritis of the hand: a review of the evidence. Drugs Aging (2010) 0.79
Protection of bovine chondrocyte phenotype by heat inactivation of allogeneic serum in monolayer expansion cultures. Ann Biomed Eng (2013) 0.78
Fighting for territories: time-lapse analysis of dental pulp and dental follicle stem cells in co-culture reveals specific migratory capabilities. Eur Cell Mater (2012) 0.78
Osteoarthritis: The Rheumatologist's Perspective. HSS J (2011) 0.77
The SOD mimic MnTM-2-PyP(5+) reduces hyaluronan degradation-induced inflammation in mouse articular chondrocytes stimulated with Fe (II) plus ascorbate. Int J Biochem Cell Biol (2013) 0.77